VERO
Price
$2.31
Change
+$0.03 (+1.32%)
Updated
Aug 28 closing price
Capitalization
4.29M
ZTEK
Price
$0.67
Change
-$0.01 (-1.47%)
Updated
Aug 28 closing price
Capitalization
68.87M
Interact to see
Advertisement

VERO vs ZTEK

Header iconVERO vs ZTEK Comparison
Open Charts VERO vs ZTEKBanner chart's image
Venus Concept
Price$2.31
Change+$0.03 (+1.32%)
Volume$35K
Capitalization4.29M
Zentek
Price$0.67
Change-$0.01 (-1.47%)
Volume$30.44K
Capitalization68.87M
VERO vs ZTEK Comparison Chart in %
Loading...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERO vs. ZTEK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERO is a Buy and ZTEK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (VERO: $2.31 vs. ZTEK: $0.67)
Brand notoriety: VERO and ZTEK are both not notable
VERO represents the Medical/Nursing Services, while ZTEK is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: VERO: 7% vs. ZTEK: 73%
Market capitalization -- VERO: $4.29M vs. ZTEK: $68.87M
VERO [@Medical/Nursing Services] is valued at $4.29M. ZTEK’s [@Pharmaceuticals: Other] market capitalization is $68.87M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERO’s FA Score shows that 1 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).

  • VERO’s FA Score: 1 green, 4 red.
  • ZTEK’s FA Score: 0 green, 5 red.
According to our system of comparison, VERO is a better buy in the long-term than ZTEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERO’s TA Score shows that 2 TA indicator(s) are bullish while ZTEK’s TA Score has 4 bullish TA indicator(s).

  • VERO’s TA Score: 2 bullish, 7 bearish.
  • ZTEK’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZTEK is a better buy in the short-term than VERO.

Price Growth

VERO (@Medical/Nursing Services) experienced а -5.14% price change this week, while ZTEK (@Pharmaceuticals: Other) price change was -4.30% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.89%. For the same industry, the average monthly price growth was +5.50%, and the average quarterly price growth was +9.92%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

Industries' Descriptions

@Medical/Nursing Services (+2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTEK($68.9M) has a higher market cap than VERO($4.29M). ZTEK YTD gains are higher at: -28.723 vs. VERO (-44.344). ZTEK has higher annual earnings (EBITDA): -8.14M vs. VERO (-32.3M). VERO has more cash in the bank: 3.88M vs. ZTEK (2.89M). ZTEK has less debt than VERO: ZTEK (1.88M) vs VERO (37.1M). VERO has higher revenues than ZTEK: VERO (60.1M) vs ZTEK (925K).
VEROZTEKVERO / ZTEK
Capitalization4.29M68.9M6%
EBITDA-32.3M-8.14M397%
Gain YTD-44.344-28.723154%
P/E RatioN/AN/A-
Revenue60.1M925K6,497%
Total Cash3.88M2.89M134%
Total Debt37.1M1.88M1,978%
FUNDAMENTALS RATINGS
VERO vs ZTEK: Fundamental Ratings
VERO
ZTEK
OUTLOOK RATING
1..100
1650
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8693
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VERO's Valuation (30) in the null industry is in the same range as ZTEK (60). This means that VERO’s stock grew similarly to ZTEK’s over the last 12 months.

ZTEK's Profit vs Risk Rating (95) in the null industry is in the same range as VERO (100). This means that ZTEK’s stock grew similarly to VERO’s over the last 12 months.

ZTEK's SMR Rating (100) in the null industry is in the same range as VERO (100). This means that ZTEK’s stock grew similarly to VERO’s over the last 12 months.

VERO's Price Growth Rating (86) in the null industry is in the same range as ZTEK (93). This means that VERO’s stock grew similarly to ZTEK’s over the last 12 months.

VERO's P/E Growth Rating (100) in the null industry is in the same range as ZTEK (100). This means that VERO’s stock grew similarly to ZTEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VEROZTEK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLAKF9.290.15
+1.62%
Deutsche Lufthansa AG
ALSSF2.900.01
+0.35%
Alsea SA
PDRX2.80N/A
N/A
PD-RX Pharmaceuticals, Inc.
WELX4.67N/A
N/A
Winland Holdings Corporation
RIOXF14.63N/A
N/A
RION CO LTD.

VERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERO has been loosely correlated with ISRG. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
+1.10%
ISRG - VERO
35%
Loosely correlated
+0.57%
CRL - VERO
34%
Loosely correlated
+0.26%
ANSLY - VERO
33%
Loosely correlated
N/A
ALC - VERO
31%
Poorly correlated
-2.36%
SHC - VERO
30%
Poorly correlated
-1.82%
More

ZTEK and

Correlation & Price change

A.I.dvisor tells us that ZTEK and TLTFF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and TLTFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTEK
1D Price
Change %
ZTEK100%
-1.73%
TLTFF - ZTEK
27%
Poorly correlated
+4.10%
VERO - ZTEK
25%
Poorly correlated
+1.10%
RVTY - ZTEK
25%
Poorly correlated
+0.72%
NVNO - ZTEK
25%
Poorly correlated
-3.75%
INGN - ZTEK
23%
Poorly correlated
+0.38%
More